These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 18483648

  • 1. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G, Figueroa M G, Lois V V, Cabrera C ME, León R A, García L H, Rojas R H.
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH, Xu Y, Mai YJ, Wang YF, Zhao YZ, Zou DH, Qiu LG.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [Abstract] [Full Text] [Related]

  • 3. International staging system for multiple myeloma.
    Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J.
    J Clin Oncol; 2005 May 20; 23(15):3412-20. PubMed ID: 15809451
    [Abstract] [Full Text] [Related]

  • 4. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V, Zemanova M, Minarik J, Bacovsky J, Ordeltova M, Indrak K, Budikova M, Dusek L, Farbiakova V.
    Neoplasma; 2006 May 20; 53(4):277-84. PubMed ID: 16830053
    [Abstract] [Full Text] [Related]

  • 5. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J.
    Ai Zheng; 2006 Apr 20; 25(4):461-4. PubMed ID: 16613681
    [Abstract] [Full Text] [Related]

  • 6. Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma.
    Hsiao LT, Yang CF, Yang SH, Gau JP, Yu YB, Hong YC, Liu CY, Liu JH, Chen PM, Chiou TJ, Tzeng CH.
    Eur J Haematol; 2012 Feb 20; 88(2):159-66. PubMed ID: 21973045
    [Abstract] [Full Text] [Related]

  • 7. New staging systems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation as first-line therapy.
    Kim H, Sohn HJ, Kim S, Kim K, Lee JH, Bang SM, Kim DH, Sohn SK, Lee JJ, Suh C.
    Biol Blood Marrow Transplant; 2006 Aug 20; 12(8):837-44. PubMed ID: 16864054
    [Abstract] [Full Text] [Related]

  • 8. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F, Minoia C, Favoino E, Prete M, Dammacco F.
    Blood Cells Mol Dis; 2009 Aug 20; 42(1):71-6. PubMed ID: 18996035
    [Abstract] [Full Text] [Related]

  • 9. [Clinical study of multiple myeloma: a report of 182 cases].
    Xu L, Wang Y, Wu W, Yan H, Gao XD, Yu Q, Shen ZX, Mi JQ.
    Zhonghua Yi Xue Za Zhi; 2010 Apr 13; 90(14):972-7. PubMed ID: 20646647
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M.
    Cancer; 2002 Sep 15; 95(6):1334-45. PubMed ID: 12216103
    [Abstract] [Full Text] [Related]

  • 11. Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.
    Sagaster V, Kaufmann H, Odelga V, Ackermann J, Gisslinger H, Rabitsch W, Zojer N, Ludwig H, Nösslinger T, Zielinski C, Drach J.
    Eur J Haematol; 2007 Mar 15; 78(3):227-34. PubMed ID: 17253972
    [Abstract] [Full Text] [Related]

  • 12. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
    Gastinne T, Leleu X, Duhamel A, Moreau AS, Franck G, Andrieux J, Lai JL, Coiteux V, Yakoub-Agha I, Bauters F, Harousseau JL, Zandecki M, Facon T, Intergroupe Francophone du Myelome (IFM).
    Eur J Haematol; 2007 Oct 15; 79(4):297-304. PubMed ID: 17692103
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF, Fu WJ, Yuan ZG, Wang DX, Chen YB, Hou J.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1655-8. PubMed ID: 17935664
    [Abstract] [Full Text] [Related]

  • 14. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
    Pertuiset E, Chevret S, Lioté F, Delauche MC, Bardin T, Dryll A, Kuntz D.
    Ann Med Interne (Paris); 1992 Oct 05; 143(8):519-24. PubMed ID: 1303595
    [Abstract] [Full Text] [Related]

  • 15. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S, Abdelhalim AN, Derby L, Mashtare TL, Miller KC, Wilding GE, Alberico RA, Gottlieb R, Klippenstein DL, Lee K, Chanan-Khan AA.
    Cancer; 2010 Jan 01; 116(1):84-92. PubMed ID: 19862816
    [Abstract] [Full Text] [Related]

  • 16. Multiple myeloma in elderly patients: prognostic factors and outcome.
    Anagnostopoulos A, Gika D, Symeonidis A, Zervas K, Pouli A, Repoussis P, Grigoraki V, Anagnostopoulos N, Economopoulos T, Maniatis A, Dimopoulos MA.
    Eur J Haematol; 2005 Nov 01; 75(5):370-5. PubMed ID: 16191085
    [Abstract] [Full Text] [Related]

  • 17. Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model.
    Mihou D, Katodritou E, Zervas K.
    Hematology; 2007 Dec 01; 12(6):527-31. PubMed ID: 17852450
    [Abstract] [Full Text] [Related]

  • 18. Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation.
    Neben K, Jauch A, Bertsch U, Heiss C, Hielscher T, Seckinger A, Mors T, Müller NZ, Hillengass J, Raab MS, Ho AD, Hose D, Goldschmidt H.
    Haematologica; 2010 Jul 01; 95(7):1150-7. PubMed ID: 20220069
    [Abstract] [Full Text] [Related]

  • 19. [Clinical features and survival of Chilean patients with multiple myeloma].
    Conté L G, Figueroa M G, Lois V V, Cabrera C ME, León R A, García L H, Rojas R H.
    Rev Med Chil; 2007 Sep 01; 135(9):1111-7. PubMed ID: 18064364
    [Abstract] [Full Text] [Related]

  • 20. [Proposal of a new staging system using scoring of multiple myeloma].
    Pasqualetti P, Collacciani A, Casale R, Colantonio D.
    Medicina (Firenze); 1989 Sep 01; 9(4):410-3. PubMed ID: 2634228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.